678TiP A phase I, first-in-human, dose escalation and expansion study of oral pan-RAF/MEK molecular glue NST-628 in subjects with solid tumors harboring RAS-MAPK pathway alterations.
Saved in:
| Title: | 678TiP A phase I, first-in-human, dose escalation and expansion study of oral pan-RAF/MEK molecular glue NST-628 in subjects with solid tumors harboring RAS-MAPK pathway alterations. |
|---|---|
| Authors: | Lemech, C.1 (AUTHOR), Luke, J.J.2 (AUTHOR), Falchook, G.S.3 (AUTHOR), Mckean, M.4 (AUTHOR), Kichenadasse, G.5 (AUTHOR), Teng, C.1 (AUTHOR), Vandross, A.L.6 (AUTHOR), Salkeni, M.A.7 (AUTHOR), Atkinson, V.G.8 (AUTHOR), Liu, J.J.9 (AUTHOR), Kennedy, A.M.10 (AUTHOR), Clark, J.10 (AUTHOR), Ryan, M.11 (AUTHOR), Schmidt-Kittler, O.11 (AUTHOR), Steinhubel, D.11 (AUTHOR), Wages, D.12 (AUTHOR), Komarnitsky, P.10 (AUTHOR), Puzanov, I.13 (AUTHOR) |
| Source: | Annals of Oncology. 2024 Supplement 2, Vol. 35, pS528-S529. 2p. |
| Database: | Academic Search Ultimate |
| ISSN: | 09237534 |
|---|---|
| DOI: | 10.1016/j.annonc.2024.08.744 |
